Document Detail


Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failure.
MedLine Citation:
PMID:  16923455     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Although increased cholesterol levels predict mortality in patients with coronary artery disease, it is unclear whether hypercholesterolemia is associated with adverse survival in patients with heart failure. A cohort of subjects derived from the Intermountain Heart Collaborative Study Registry (1993 to 2003) who had ejection fractions < or = 40% or clinical diagnoses of heart failure and long-term follow-up for death were studied (n = 1,646). Total cholesterol (TC) was divided into quartiles: quartile 1, < 141.3 mg/dl; quartile 2, 141.3 to 167.9 mg/dl; quartile 3, 168.0 to 201.0 mg/dl; and quartile 4, > 201.0 mg/dl. Multivariate Cox regression models were used to evaluate the associations of cholesterol, statin therapy, and C-reactive protein to mortality. The mean age was 65.5 years; 65% of the subjects were men and 65% had coronary artery disease. Although 53% were using statins, statin use was not different across TC quartiles. Average time to death was 2.4 years (maximum 10). Mortality for quartile 4 versus quartile 1 was not different (hazard ratio [HR] 1.12, p = 0.52); mortality was reduced for quartile 3 versus quartile 1 (HR 0.66, p = 0.027) and tended to be reduced for quartile 2 versus quartile 1 (HR 0.77, p = 0.14). Subanalysis of patients not using statins (n = 737, death = 20.2%) found no association between TC and survival (for quartile 3 vs quartile 1, HR 0.97, p = 0.89), but for patients using statins (n = 848, death = 16.3%), the effect was even greater for quartile 3 versus quartile 1 (HR 0.40, p = 0.002) than in the overall population. Nonsurvivors had higher levels of C-reactive protein than survivors. In conclusion, elevated TC appears to be associated with improved survival. The effect was stronger in patients receiving statin therapy, but the cause of this differential effect is uncertain.
Authors:
Heidi T May; Joseph B Muhlestein; John F Carlquist; Benjamin D Horne; Tami L Bair; Beverly A Campbell; Abdallah G Kfoury; Joseph L Lyon; Han Kim; Dale G Renlund
Related Documents :
2215615 - Regression of coronary artery disease as a result of intensive lipid-lowering therapy i...
8675545 - Addressing the spectrum of hypercholesterolemia.
12538425 - Statin therapy interacts with cytomegalovirus seropositivity and high c-reactive protei...
7572685 - Effect of pravastatin on progression and regression of coronary atherosclerosis and ves...
1716425 - Quantitation of early myocardial ischemia using acridine orange fluorescence--an experi...
17689895 - Influence of menstrual cycle on cardiac performance.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2006-07-07
Journal Detail:
Title:  The American journal of cardiology     Volume:  98     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2006 Sep 
Date Detail:
Created Date:  2006-08-22     Completed Date:  2006-09-28     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  653-8     Citation Subset:  AIM; IM    
Affiliation:
LDS Hospital, Salt Lake City, Utah, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Biological Markers / blood
C-Reactive Protein / metabolism*
Cholesterol / blood*
Female
Follow-Up Studies
Heart Failure / blood,  drug therapy,  mortality*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Male
Middle Aged
Retrospective Studies
Risk Factors
Survival Rate / trends
Time Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 57-88-5/Cholesterol; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relation of C-reactive protein and tumor necrosis factor-alpha to ambulatory blood pressure variabil...
Next Document:  Prediction of outcome in patients undergoing surgery for severe tricuspid regurgitation following mi...